Latest Competition News

Count Limited has declared a fully franked interim dividend of 2.00 cents per share for 1HFY26, with a Dividend Reinvestment Plan allocation price fixed at $1.08. The company will issue over 650,000 new shares to participating shareholders.

Careteq Limited has successfully raised $2.2 million through a two-tranche share placement, with a significant portion subject to upcoming shareholder approval. The funds aim to support project acquisitions, debt reduction, and working capital needs.

RLF AgTech has completed its restructuring phase and is now shifting gears towards aggressive commercial execution under new CEO Stuart Upton. The company outlined its growth strategy and financial results in a recent investor webinar, signalling a clear path to profitability.

Oncosil Medical Ltd’s OSLOE securities have been suspended from trading by the ASX due to non-compliance with listing rules, raising questions about the company’s next steps.

Li-FT Power has satisfied a critical condition precedent in its proposed acquisition of Winsome Resources, advancing the lithium explorer's path to consolidation. The deal hinges now on shareholder and court approvals.

Kalgoorlie Gold Mining is set to begin multiple drilling programs at its Pinjin Gold Project in April 2026, targeting resource expansion and new discoveries across key deposits and unexplored zones.

Briscoe Group Limited reported record full-year sales of NZD 798.8 million for FY2026, with net profit after tax dipping slightly to NZD 59.2 million. The company maintained dividends and invested heavily in supply chain upgrades despite a challenging retail environment.

IRIS Metals has secured a farm-in agreement to earn up to 100% ownership of the Finley Basin Tungsten Project in Montana, marking a strategic expansion into a critical mineral vital for defence and advanced manufacturing.

Aerometrex has won multiple government contracts worth $2.5 million over three years, reinforcing its position as a trusted local provider and enhancing revenue visibility.

Imugene Limited reports striking early results from its Phase 1b azer-cel trial, achieving a 100% overall response rate in chronic lymphocytic leukemia and 80% in marginal zone lymphoma, while broadening its study to include a BTK inhibitor combination.

HighCom Limited has successfully raised nearly $800,000 through a Share Purchase Plan, adding to a prior $7 million placement to fund product upgrades and sales growth.

Metal Bank reports exceptional gold recovery results from its Seven Leaders Prospect near Kalgoorlie, highlighting a 72.5% gravity recovery and over 99% leaching efficiency, underpinning its near-term production ambitions.